01 Dec 2023 Bupropion: a discussion of its efficacy and safety
We invite you to watch the presentation: Bupropion: a discussion of its efficacy and safety, given at the October 2023 TI Annual Course by Dr. Cait O’Sullivan and Dr. Vincent Wong.
The aims of this practical and evidence-informed presentation are to:
- Identify the best available evidence for bupropion as a pharmacologic treatment for depression, anxiety, ADHD;
- Describe what is known about bupropion’s dose response as a pharmacologic treatment for depression, anxiety, ADHD;
- Understand toxic thresholds and effects of bupropion;
- Discuss the British Columbia Drug & Poison Information Centre’s (DPIC) experience with bupropion.
Dr. Cait O’Sullivan has a clinical pharmacy background in acute general medicine, residential care, and community practice. She received a Bachelor of Arts from the University of New Brunswick (Honours, Medical Anthropology), a Bachelor of Science in Pharmacy from Dalhousie University, and a Doctor of Pharmacy Degree from the University of Washington. Cait has a research interest in the drug approval process and clinical practice guideline methodology.
Dr. Vincent Wong is a family physician based in the Lower Mainland who works part-time with the BC Drug and Poison Information Centre (DPIC) as a Physician Liaison. In this role, he reviews & follows-up with prescribers for poison prevention after a reported poisoning incident or a near-miss, as well as provide poison prevention education to medical residents and physicians. He is passionate about medical education and serves as a Co-Site Director and Assessment Co-Lead for the UBC Family Practice Residency Program, in addition to teaching medical students and residents at the UBC Health Clinic. He also currently serves as the Vice-President of the BC College of Family Physicians.